Trump judge sets limits on what evidence he can publicly share in D.C. election case
The judge partially sided with Trump’s lawyers, who challenged a broader proposed ban on which evidence could be disclosed.
Wholesale prices rose 0.3% in July, higher than expected
The producer price index rose 0.3% for the month, slightly higher than expectations.
Biden attorneys are in talks with special counsel Robert Hur over terms to interview the president
Attorney General Merrick Garland appointed Hur to investigate Biden’s handling of classified documents after his term as vice president ended.
GOP Oversight Chairman Comer vows to subpoena the Biden family
Comer’s promise follows a Republican-led investigation that has largely focused on Hunter Biden’s foreign business dealings but shown no direct links to the president.
Treasury yields increase after producer prices are a touch hotter than expected
U.S. Treasury yields rose on Friday as traders assessed a slightly higher-than-expected measure of wholesale inflation for July.
Here are ways to adjust your portfolio as some experts predict a soft landing for the economy
Some experts are now expecting a soft landing for the economy rather than a mild recession. Here’s how advisors are adjusting portfolios.
Biden seeks nearly $40 billion in funding for Ukraine, disaster relief and border
The White House wants nearly $40 billion in supplemental funding to boost Ukraine’s capabilities, respond to natural disasters and manage the border.
These 10 medications are likely targets for Medicare price negotiations this fall
It’s still unclear which drugs Medicare will select, but several companies have revealed in court filings that four of their medications are targets.
Novo Nordisk to acquire obesity drug maker Inversago Pharma for up to $1 billion
Inversago’s drugs use a different approach than most treatments in the obesity and diabetes space.
Watch out: September’s poor market track record is getting worse — especially for certain stocks
CNBC analysis of seasonal data showed there could be more churn ahead as next month is typically the weakest in the S&P 500.
